Gastrointestinal Cancer News

Patients with a high fatty liver index, a noninvasive method used to predict non-alcoholic fatty liver disease, showed a higher risk for colorectal adenomas, according to new research.

Direct-acting antiviral treatment for hepatitis C did not correlate with an increased risk for hepatocellular carcinoma in a large cohort study of both treated and untreated patients with or without cirrhosis. Those with incident HCC after DAA treatment had higher risk factors at baseline.

Fujifilm Medical Systems U.S.A. Inc. - Endoscopy has partnered with Fight Colorectal Cancer to support “One Million Strong,” a national movement that raises awareness of more than one million colorectal cancer survivors living in the United States, according to a press release.

SAN ANTONIO — Creating a dynamic regulatory environment requires the FDA is responsive to societal demands in conjunction with emerging scientific advances, according to Richard Pazdur, MD.

The American Cancer Society’s Community Health Advocates Implementing Nationwide Grants for Empowerment and Equity (CHANGE) grant program effectively increased colorectal cancer screening rates in health centers that serve low-income and underserved communities, according to new research.

Elevated levels of hepatitis B DNA and hepatitis B surface antigen correlated significantly with an increased risk for liver cancer, according to recently published data.

The FDA today approved trastuzumab-dkst, the first biosimilar to treat patients with breast cancer or gastric or gastroesophageal junction adenocarcinoma whose tumors overexpress the HER-2 gene.

The FDA approved a next-generation sequencing-based in vitro diagnostic test that can detect genetic mutations in 324 genes and two genomic signatures in any solid tumor.

Tannerella forsythia — bacteria commonly linked to gum disease — appeared associated with a 21% increased risk for esophageal cancer, according to study results.

The CDC has released a public-use research database that combines data from CDC’s National Program of Cancer Registries and NCI’s SEER program.